FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Northwind Pharmaceuticals Tadalafil Tablets Recall

Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b)…

Northwind Pharmaceuticals LLC · Indianapolis, IN

Risk level
Class II
Reported by FDA
May 3, 2023
Recall ID
D-0553-2023
Check your lot numberHow we source this data

Summary

Northwind Pharmaceuticals recalled Tadalafil Tablets starting Mar 16, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0553-2023 on May 3, 2023. Reason: CGMP Deviations. Status: Ongoing.

Why it was recalled

CGMP Deviations

Product description

Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.

Lot numbers, UPCs & expiration codes

a) Lot #: F113892002, Exp. Date 08/31/2023; F113892201, Exp. Date 11/30/2023 b) Lot #: F113892001, Exp. Date 08/31/2023; F113892202, Exp. Date 11/30/2023; F113892203, Exp. Date 12/31/2023

Where it was sold

Nationwide with the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0553-2023
Classification
Class II
Status
Ongoing
Recall initiated
Mar 16, 2023
FDA report date
May 3, 2023
Quantity
a)164 bottles; b) 198 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Northwind Pharmaceuticals LLC

Original FDA data

Every field from FDA enforcement report D-0553-2023, exactly as published.

Show all FDA fields
City
Indianapolis
State
IN
Status
Ongoing
Country
United States
Event ID
91944
Address
4838 Fletcher Ave Ste 1000
Code information
a) Lot #: F113892002, Exp. Date 08/31/2023; F113892201, Exp. Date 11/30/2023 b) Lot #: F113892001, Exp. Date 08/31/2023; F113892202, Exp. Date 11/30/2023; F113892203, Exp. Date 12/31/2023
Postal code
46203-1642
Report date
May 3, 2023
Product type
Drugs
Recall number
D-0553-2023
Classification
Class II
Recalling firm
Northwind Pharmaceuticals LLC
Product quantity
a)164 bottles; b) 198 bottles
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Distribution pattern
Nationwide with the United States
Recall initiation date
Mar 16, 2023
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Apr 26, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0553-2023, published May 3, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls